Szeman Chan

Title: Szeman Chan: Innovator in Engineered Ligands

Introduction

Szeman Chan is a notable inventor based in Havertown, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered ligands. His work focuses on enhancing the stability and functionality of these ligands for therapeutic applications.

Latest Patents

Szeman Chan holds a patent for "Materials and methods of using engineered ligands." This patent describes compositions and kits that include an engineered TL1A ligand. The ligand exhibits high stability and minimal binding to the decoy receptor DcR3 while retaining its functional activity through binding to its cell surface receptor, DR3. Additionally, the patent outlines methods for making the engineered TL1A ligand and its application in treating diseases or disorders by administering the ligand to subjects.

Career Highlights

Szeman Chan is currently employed at Janssen Biotech, Inc., where he continues to advance his research in engineered ligands. His innovative work has the potential to impact various therapeutic areas, particularly in immunology.

Collaborations

Some of Szeman Chan's coworkers include Adam Zwolak and Rajkumar Ganesan. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.

Conclusion

Szeman Chan's contributions to the development of engineered ligands highlight his role as an innovator in biotechnology. His patent and ongoing work at Janssen Biotech, Inc. demonstrate his commitment to advancing medical science.